Aligning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

MemorandumPublished 25/12/05Open the original

Summary

President Trump directs the HHS Secretary and CDC Director to review peer countries' core childhood vaccine recommendations and, if superior, align the U.S. schedule, noting the U.S. recommended vaccines for 18 diseases in January 2025 versus 10 in Denmark, 14 in Japan and 15 in Germany.

By industry

Healthcare & Drug Pricing1 trading day−0.9%p15 stocks5 trading days−0.1%p15 stocks20 trading days+1.2%p15 stocks
“update the United States core childhood vaccine schedule”

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
25/12/04	0.0%	0.0%
25/12/05	−0.6%	+0.2%
25/12/08	−1.4%	0.0%
25/12/09	−2.1%	−0.2%
25/12/10	−0.8%	+0.4%
25/12/11	+0.7%	+0.8%
25/12/12	+1.0%	−0.4%
25/12/15	+2.2%	−0.5%
25/12/16	+0.7%	−0.9%
25/12/17	+0.4%	−1.7%
25/12/18	+0.3%	−1.2%
25/12/19	+0.9%	−0.5%
25/12/22	+1.6%	+0.1%
25/12/23	+1.5%	+0.5%
25/12/24	+2.1%	+0.8%
25/12/26	+2.4%	+0.8%
25/12/29	+2.2%	+0.5%
25/12/30	+2.1%	+0.4%
25/12/31	+1.6%	−0.3%
26/01/02	+2.1%	−0.2%
26/01/05	+1.7%	+0.5%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$128.2M
120,016 sh
$128.2M
Filed 25/11/25
Traded 25/11/24
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$101.4M
96,516 sh
$101.4M
Filed 25/11/20
Traded 25/11/19
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$57.7B
55,908 sh
$57.7B
Filed 25/11/17
Traded 25/11/14
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$107M
103,871 sh
$107M
Filed 25/11/17
Traded 25/11/14
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$18.1B
17,567 sh
$18.1B
Filed 25/11/17
Traded 25/11/14
John G. MorikisDirector
BuyJohnson & Johnson
Buy
Johnson & Johnson
JNJ
$257.7K
1,250 sh
$257.7K
Filed 25/12/01
Traded 25/11/26
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$47.9M
47,073 sh
$47.9M
Filed 25/11/13
Traded 25/11/12
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$46.6M
45,246 sh
$46.6M
Filed 25/11/14
Traded 25/11/13
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$32.8M
33,154 sh
$32.8M
Filed 25/11/12
Traded 25/11/11
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$30.2M
28,768 sh
$30.2M
Filed 25/11/20
Traded 25/11/19
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$30.2M
30,633 sh
$30.2M
Filed 25/11/12
Traded 25/11/11
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$28.7M
31,016 sh
$28.7M
Filed 25/11/06
Traded 25/11/05
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$26.5M
26,761 sh
$26.5M
Filed 25/11/12
Traded 25/11/11
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$25.3M
23,916 sh
$25.3M
Filed 25/11/24
Traded 25/11/21
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$24M
23,863 sh
$24M
Filed 25/11/13
Traded 25/11/12
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$23.7M
23,568 sh
$23.7M
Filed 25/11/13
Traded 25/11/12
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.2M
21,107 sh
$22.2M
Filed 25/11/20
Traded 25/11/19
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.2M
22,131 sh
$22.2M
Filed 25/11/13
Traded 25/11/12
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$21.9M
22,127 sh
$21.9M
Filed 25/11/12
Traded 25/11/11
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$21.8M
21,559 sh
$21.8M
Filed 25/11/13
Traded 25/11/12